Zusammenfassung
Die Komplexität der Behandlung bipolarer affektiver Störungen ergibt sich daraus, dass im Krankheitsverlauf fünf verschiedene Symptomkonstellationen auftreten können (Depression, Hypomanie, Manie, gemischte Episode, Rapid Cycling), was oft zu einer polypharmazeutischen Therapie führt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Baldessarini RJ, Tondo L, Ghiani C, Lepri B (2010) Illness risk following rapid versus gradual discon- tinuation of antidepressants. Am J Psychiatry 167(8): 934–941
Cipriani A, Barbui C, Salanti G et al (2011) Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 378(9799): 1306–1315
DGBS e.V., DGPPN e.V. (2012) S3-Leitlinie zur Diagnostik und Therapie Bipolarer törungen. Langversion 1.0, Mai 2012
Geddes JR, Calabrese JR, Goodwin GM (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five ran- domised trials. Br J Psychiatry 194(1): 4–9
Geddes JR, Goodwin GM, Rendell J et al (2010) Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open- label trial. Lancet 375(9712): 385–395
Ghaemi SN, Ostacher MM, El-Mallakh RS et al (2010) Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term ffectiveness and safety. J Clin Psychiatry 71(4): 372–380
Fountoulakis KN, Kasper S, Andreassen O et al (2012) Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 262(Suppl 1): 1–48
Leon AC, Solomon DA, Li C et al (2012) Antiepileptic drugs for bipolar disorder and the risk of sui- cidal behavior: a 30-year observational study. Am J Psychiatry 169(3): 285–291
Li CT, Bai YM, Huang YL et al (2011) Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Br J Psychiatry 200(1): 45–51
Licht RW, Nielsen JN, Gram LF et al (2010) Lamotrigine versus lithium as aintenance treatment in bipolar I disorder: an open, randomized effectiveness study imicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord 12(5): 483–493
McIntyre RS, McElroy SL, Eudicone JM et al (2011) A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder. Prim Care Companion CNS Disord 13(6)
McKnight RF, Adida M, Budge K (2012) Lithium toxicity profile: a systematic review and meta- analysis. Lancet 379(9817): 721–728
Nemeroff CB, Evans DL, Gyulai L et al (2001) Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 158(6): 906–912
Parikh SV, LeBlanc SR, Ovanessian MM (2010) Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Can J Psychiatry 55(3): 136–143
Perlis RH, Ostacher MJ, Miklowitz DJ et al (2010) Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. J Clin Psychiatry 71(2): 194–200
Post RM, Leverich GS, Altshuler LL et al (2012) Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. J Clin Psychiatry. E-pub ahead of print
Young AH, McElroy SL, Bauer M et al; EMBOLDEN I (Trial 001) Investigators (2010) A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71(2): 150–162
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Benkert, O., Hippius, H. (2013). Medikamente zur Behandlung bipolarer affektiver Störungen. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29810-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-29810-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29809-7
Online ISBN: 978-3-642-29810-3
eBook Packages: Medicine (German Language)